Companies / Editas Medicine, Inc. / Activity
Activity — Editas Medicine, Inc.
6 moves.
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | O'Neill Gilmore Neil CEO | Sell | Common Stock | $10.9K | -5K -2.00% | 263,693 0.17% of shares | low |
| Mar 3, 2026 | Burkly Linda Executive | Sell | Common Stock | $1.5K | -749 -1.09% | 68,028 0.04% of shares | low |
| Mar 3, 2026 | Parison Amy Executive | Sell | Common Stock | $957 | -474 -2.98% | 15,434 0.01% of shares | low |
| Mar 12, 2026 | O'Neill Gilmore Neil CEO | Grant | Stock Option (right to buy) | — | +1.0M | 1,015,200 0.66% of shares | low |
| Mar 12, 2026 | Parison Amy Executive | Grant | Stock Option (right to buy) | — | +293K | 292,856 0.19% of shares | low |
| Mar 12, 2026 | Burkly Linda Executive | Grant | Stock Option (right to buy) | — | +293K | 292,856 0.19% of shares | low |